Financials
- Market Capitalization 594.65 B
- Employee 141 K
- Founded N/A
- CEO Joaquin Duato
- Website www.jnj.com
- Headquarter New Jersey, United States
- FIGI BBG000BMHYD1
- Industry Fabricantes de medicamentos — general
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
18.82
Relación precio/flujo de caja
5.35
Dividendos por acción
5.14
Rendimiento por dividendo, %
2.48
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 10 | LLY Eli Lilly and Company Common Stock | 1156.47 USD | +0.25% | -4.55% | +3.70% | +46.99% | 1.09 T USD | ||
| 25 | ABBV AbbVie Inc. Common Stock | 244.22 USD | -0.23% | -2.93% | +9.81% | +29.72% | 431.49 B USD | ||
| 41 | MRK Merck & Company, Inc. Common Stock | 123.60 USD | +2.32% | -1.46% | +7.61% | +50.49% | 305.27 B USD | ||
| 46 | NVS Novartis AG | 150.78 USD | +0.28% | -2.66% | -0.42% | +30.33% | 287.71 B USD |